Patents Assigned to Boehringer Igelheim International GmbH
  • Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds
    Patent number: 9034822
    Abstract: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 19, 2015
    Assignee: Boehringer Igelheim International GmbH
    Inventors: Joanne Van Ryn, John Edward Park, Norbert Hauel, Ulrich Kunz, Tobias Litzenburger, Keith Canada, Sanjaya Singh, Alisa Waterman
  • Process for the characterization of human rhinoviruses
    Patent number: 5340713
    Abstract: The present invention relates to a method of characterizing viruses and the use thereof for classification. According to the invention, a cDNA copy of a first virus is made and the cDNA is amplified and cleaved using at least one restriction endonuclease. The location of restriction fragments is mapped and compared to that of other viruses. Primers useful for amplifying the cDNA may be derived from sequences found in the 5' non-coding regions of picornavirus including human rhinovirus.
    Type: Grant
    Filed: June 22, 1990
    Date of Patent: August 23, 1994
    Assignee: Boehringer Igelheim International GmbH
    Inventors: Helge Torgersen, Timothy Skern, Dieter Blaas